HRJ

official impact factor 1.46

Open Access Highly Access Review

A review of HIV prevention among young injecting drug users: A guide for researchers

Kate A Dolan* and Heather Niven

Author Affiliations

The Program of International Research and Training National Drug and Alcohol Research Centre The University of New South Wales, Sydney, Australia

For all author emails, please log on.

Harm Reduction Journal 2005, 2:5 doi:10.1186/1477-7517-2-5

Published: 17 March 2005

Abstract

Young people aged 15–24 years account for fifty percent of all new AIDS cases worldwide. Moreover, half of all new HIV infections are associated with injection drug use. The average age for initiation into injecting drug use is 20 years of age. This paper investigates whether HIV prevention programs have reduced risk behaviours in young people.